We are no longer in an era where heart failure is merely seen as an end-stage cardiac condition. We now recognize it as a complex, multi-system syndrome—one that begins silently, progresses unpredictably, and if not treated aggressively, can lead to devastating consequences.
Heart failure today is not just about a weak heart—it's about how the body compensates, how the lungs, kidneys, liver, and even the brain are affected. It spans across:
HFrEF – Heart Failure with reduced ejection fraction
HFpEF – Preserved ejection fraction, especially in diabetic and hypertensive populations
Right Heart Failure
Acute Decompensated Heart Failure
And increasingly, Cardiogenic Shock
The spectrum has widened. And so must our approach.
We are diagnosing advanced heart failure even in patients in their 30s and 40s. Why?
Rising prevalence of diabetes, hypertension, and obesity
Undiagnosed congenital or valvular disease
Post-COVID myocarditis and viral infections
And perhaps most alarmingly, delayed referrals
This is why awareness, early diagnosis, and referral to heart failure teams are crucial.
We are now armed with powerful pharmacological and device-based therapies:
ARNIs, SGLT2 inhibitors, and newer beta-blockers are improving survival
CRT and ICD implantation have redefined long-term rhythm management
Mechanical circulatory support, such as IABP, Impella, and ECMO, have changed how we manage shock
And in select patients, Heart Transplantation remains the gold standard
At Rela Hospital, we offer all levels of heart failure therapy—from medication titration to mechanical support and transplant.
In the past, many patients in cardiogenic shock were considered too sick to save. Today, with ECMO, we can stabilize, oxygenate, and support organs until the heart recovers or until a transplant becomes possible.
We’ve successfully bridged several patients to transplant, and others to recovery, with our dedicated ECMO and heart failure unit.
Many of our heart failure patients also develop pulmonary hypertension, lung congestion, or RV failure. This is where our Heart & Lung Team steps in—to assess candidacy for combined transplant, or dual support systems.
At Rela Hospital, we are proud to say we’ve performed high-risk mitral valve repairs, minimally invasive surgeries, and heart and lung transplants in even the most complex patients.
The future lies in:
Personalized heart failure clinics
Artificial hearts (VADs) becoming more accessible
Telemonitoring & remote titration
Genetic screening in idiopathic cardiomyopathies
Heart failure today is not a death sentence. It is a manageable, and in many cases, reversible condition—if diagnosed early and treated holistically.
I urge all clinicians, cardiologists, general physicians, and intensivists—refer early. Let's not wait for ejection fraction to drop below 20% before taking action. Let’s create a continuum of care—from diagnosis to transplant—and give our patients the full spectrum of hope.
Thank you all, and let’s continue to breathe new life into broken hearts.
Dr. Srinath Vijayasekharan
Senior Consultant – Cardiothoracic Surgery
Heart & Lung Transplant Surgeon
Rela Hospital, Chennai